The COVID-19 IgG ELISA test is intended for the detection of IgG antibodies to SARS-CoV-2 in human serum or plasma to indicate adaptive Immunity, recent or prior SARS-COV-2 infection and attenuation to re-infection. It has demonstrated excellent performance characteristics in independent validation by St. George’s University of London, UK and Liverpool School of Tropical Medicine, UK.